2011 -Drug-eluting stents do we respect the on-label use in our daily practice ,
Progress in neuropathology. Grune & Stratton, 1971. ,
Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations, The Lancet, vol.355, issue.9205, pp.688-700, 2000. ,
DOI : 10.1016/S0140-6736(99)11181-4
??pid??miologie des syndromes coronaires aigus en France et en Europe, Annales de Cardiologie et d'Ang??iologie, vol.59, pp.37-41, 2010. ,
DOI : 10.1016/S0003-3928(10)70008-1
New evidence for cardiac benefit of postmenopausal hormone therapy, Climacteric, vol.80, issue.1, pp.5-10, 2017. ,
DOI : 10.1097/gme.0b013e3181f0839a
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, The Lancet, vol.364, issue.9438, pp.937-52, 2004. ,
DOI : 10.1016/S0140-6736(04)17018-9
Age-specific relevance of usual blood pressure to vascular mortality, The Lancet, vol.361, issue.9366 ,
DOI : 10.1016/S0140-6736(03)13064-4
Cardiovascular risk assessment in patients with diabetes, Diabetology & Metabolic Syndrome, vol.360, issue.24, 2017. ,
DOI : 10.1056/NEJMoa0805796
Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era, American Heart Journal, vol.167, issue.4, 2014. ,
DOI : 10.1016/j.ahj.2013.12.017
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT), EuroIntervention, vol.4, issue.1, pp.77-83, 2008. ,
DOI : 10.4244/EIJV4I1A14
Cholesterol Reduction Yields Clinical Benefit : Impact of Statin Trials, Circulation, vol.97, issue.10, 1998. ,
DOI : 10.1161/01.CIR.97.10.946
High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training, Integrative Medicine Research, vol.5, issue.3, 2016. ,
DOI : 10.1016/j.imr.2016.07.001
Inflammation in atherosclerosis, Nature, vol.103, issue.6917, pp.868-74, 2002. ,
DOI : 10.1074/jbc.274.45.32048
-A definition of initial, fatty streak, and intermediate lesions in atherosclerosis, 1994. ,
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Circulation, vol.92, issue.5, pp.1355-74, 1995. ,
DOI : 10.1161/01.CIR.92.5.1355
Pathogenesis of atherosclerosis a multifactorial process, 2002. ,
Le concept de la plaque d'athérome vulnérable ou instable, pp.4-196, 2011. ,
A simplified lesion classification for predicting success and complications of coronary angioplasty, The American Journal of Cardiology, vol.85, issue.10, pp.1179-84, 2000. ,
DOI : 10.1016/S0002-9149(00)00724-4
Plaque d'athérome physiopathologie et évaluation -SFCardio http://www.sfcardio.fr/sites ,
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries, New England Journal of Medicine, vol.316, issue.22, pp.1371-1376, 1987. ,
DOI : 10.1056/NEJM198705283162204
Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J. 1 oct, vol.33, issue.20, pp.2569-619, 2012. ,
Guidelines on myocardial revascularization, 2014. ,
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease, New England Journal of Medicine, vol.360, issue.10, 2009. ,
DOI : 10.1056/NEJMoa0804626
Revascularisation coronaire : quoi de neuf depuis Syntax ?, 2013. ,
-Thirty years of the balloon catheter--A. Grüntzig and percutaneous balloon angioplasty, Cas Lek Cesk, vol.143, issue.12, pp.866-71, 2004. ,
Endoprothèses coronaires et angioplastie transluminale des artères coronaires, 2016. ,
fixant les règles de classification des dispositifs médicaux, pris en application de l'article R, 2006. ,
has-sante.fr/portail/upload/docs/application/pdf/2009- 12/brochure_presentation_cnedimts_02.pdf 54. HAS -Les critères d'évaluation de la CNEDiMTS ,
Comité économique des produits de santé, 2017. ,
Nouveau contrat de bon usage des médicaments et produits et prestations, 2013. ,
de la jeunesse et des sports -La tarification à l'activité ,
http://www.omedit-normandie.fr/media-files/note-explicative-audits-dmi-rapport-d-etape, 2016. ,
One-Year Follow-Up of The Stent Restenosis (STRESS I) Study 11This study was supported in part by Johnson & Johnson Interventional Systems (Cordis), Incorporated, Warren, New Jersey., The American Journal of Cardiology, vol.81, issue.7, pp.860-865, 1998. ,
DOI : 10.1016/S0002-9149(98)00004-6
792-1 One Year Clinical Follow-up of the Benestent Trial, Journal of the American College of Cardiology, vol.25, issue.2, 1995. ,
DOI : 10.1016/0735-1097(95)93011-Z
Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials, The American Journal of Medicine, vol.116, issue.4 ,
DOI : 10.1016/j.amjmed.2003.08.035
Angiographic and clinical outcome of intracoronary, 1992. ,
Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty, Circulation, vol.85, issue.3, 1992. ,
DOI : 10.1161/01.CIR.85.3.916
Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention, Circulation, vol.124, issue.14, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.045229
Radial force of coronary stents : a comparative analysis Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv, mars, vol.46, issue.3, pp.380-91, 1999. ,
Assessment of the trackability, flexibility, and conformability of coronary stents: A comparative analysis, Catheterization and Cardiovascular Interventions, vol.346, issue.4, pp.496-503, 2003. ,
DOI : 10.1002/ccd.10583
URL : https://hal.archives-ouvertes.fr/hal-00092259
Intracoronary stenting and angiographic results : strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial, 2003. ,
DOI : 10.1016/s1062-1458(03)00305-2
Intracoronary stenting and angiographic results : strut thickness effect on restenosis outcome (ISAR-STEREO) trial, 2001. ,
DOI : 10.1161/01.cir.103.23.2816
Elastic recoil of coronary stents : a comparative analysis Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv, pp.112-121, 2000. ,
Endoprothèses coronaires : critères de choix et évaluation d'une fiche technique type, 2005. ,
Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. The Lancet. 2 déc, pp.1895-1902, 2000. ,
Évolution technologique des stents coronaires: où en est-on? Arch Mal Coeur Vaiss Prat, pp.9-14, 2014. ,
A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts, ACC Current Journal Review, vol.13, issue.1, 2003. ,
DOI : 10.1016/j.accreview.2003.10.045
La d??finition de la rest??nose vue par le clinicien??: aspects m??thodologiques et angiographiques, Pathologie Biologie, vol.52, issue.4 ,
DOI : 10.1016/j.patbio.2004.02.001
Incidence of restenosis after successful coronary angioplasty : a timerelated phenomenon ,
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials, Journal of the American College of Cardiology, vol.40, issue.12, 2002. ,
DOI : 10.1016/S0735-1097(02)02597-4
URL : https://doi.org/10.1016/s0735-1097(02)02597-4
Incidence of restenosis after successful coronary angioplasty: a time- related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months, Circulation, vol.77, issue.2, pp.361-71, 1988. ,
DOI : 10.1161/01.CIR.77.2.361
Analysis of 1-year clinical outcomes in the SIRIUS trial, 2004. ,
Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation, Cardiovascular Revascularization Medicine, vol.13, issue.6, 2012. ,
DOI : 10.1016/j.carrev.2012.10.003
Drug-eluting versus bare-metal stents. The Medical Roundtable Cardiovascular Edition. https://themedicalroundtable.com/article/drug-eluting-versus-bare-metal-stents ,
Rôle de l'adventice dans la resténose post-angioplastie coronaire, Sang Thromb Vaiss. 26 févr, vol.10, issue.1, pp.12-21, 1998. ,
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods, The Lancet, vol.373, issue.9667, pp.897-910, 2009. ,
DOI : 10.1016/S0140-6736(09)60325-1
Assessment of Intermediate Severity Coronary Lesions in the Catheterization Laboratory, Journal of the American College of Cardiology, vol.49, issue.8, pp.839-887, 2007. ,
DOI : 10.1016/j.jacc.2006.10.055
est-ce que la FFR ? Comment l'utiliser ? 2013. http://www.realites-cardiologiques.com/wp-content, 2013. ,
Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis, Journal of the American College of Cardiology, vol.49, issue.21, pp.2105-2116, 2007. ,
DOI : 10.1016/j.jacc.2007.01.087
Fractional Flow Reserve???Guided PCI versus Medical Therapy in Stable Coronary Disease, New England Journal of Medicine, vol.367, issue.11 ,
DOI : 10.1056/NEJMoa1205361
SFCardio -Angioplastie coronaire : les lésions résistantes, 2010. ,
Guideline for Percutaneous Coronary intervention, 2011. ,
2014 -A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system : the CENTURY II trial ,
Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: Complete revascularisation versus conservative strategy ,
AH -Management of multivessel coronary disease in STsegment elevation myocardial infarction, Curr Cardiol Rep, 2015. ,
Safety and efficacy of drug-eluting and bare metal stents, 2009. ,
Clinical outcomes and stent thrombosis following off-label use of drugeluting stents, JAMA. 9 mai, vol.297, issue.18, 2007. ,
Outcomes and Complications With Off-Label Use of Drug-Eluting Stents, JACC: Cardiovascular Interventions, vol.1, issue.4, pp.405-419, 2008. ,
DOI : 10.1016/j.jcin.2008.06.005
Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use, The Korean Journal of Internal Medicine, vol.31, issue.4, 2016. ,
DOI : 10.3904/kjim.2015.045
Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival, 2008. ,
Association of Intravascular Ultrasound- and Optical Coherence Tomography-Assessed Coronary Plaque Morphology With Periprocedural Myocardial Injury in Patients With Stable Angina Pectoris, Circulation Journal, vol.79, issue.9, pp.1944-53, 2015. ,
DOI : 10.1253/circj.CJ-14-1375